Urogen Pharma stock forecast
Urogen Pharma (UR8) Stock Forecast & Price Target
UR8 Analyst Ratings
UR8 Stock 12 Month Forecast
Average Price Target
€56.22▲(142.87% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ram Selvaraju | H.C. Wainwright | €67.79 | buy | 192.85%Upside | Reiterated | 11/05/26 | ||
| Leland Gershell | Oppenheimer | €54.24 | buy | 134.28%Upside | Reiterated | 11/05/26 | ||
| Kelsey Goodwin | Piper Sandler | €52.43 | buy | 126.47%Upside | Reiterated | 11/05/26 | ||
| Kevin DeGeeter | Ladenburg Thalmann & Co. | €58.76→€56.04 | buy | 142.09%Upside | Reiterated | 11/05/26 | ||
| Michael Schmidt | Guggenheim | €52.43→€50.62 | buy | 118.66%Upside | Reiterated | 11/04/26 | ||
| Tara Bancroft | TD Cowen | €45.20→€54.24 | buy | 134.28%Upside | Assigned | 08/05/26 | ||
| Paul Choi | Goldman Sachs | €39.77→€43.39 | hold | 87.42%Upside | Reiterated | 08/05/26 | ||
| Amin Makarem | Jefferies | €36.16 | buy | 56.19%Upside | Initiated | 04/09/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ram SelvarajuH.C. Wainwright | BuyReiterated€67.79 | 11/05/26 | 192.85%Upside | ||
| Leland GershellOppenheimer | BuyReiterated€54.24 | 11/05/26 | 134.28%Upside | ||
| Kelsey GoodwinPiper Sandler | BuyReiterated€52.43 | 11/05/26 | 126.47%Upside | ||
| Kevin DeGeeterLadenburg Thalmann & Co. | BuyReiterated€58.76→€56.04 | 11/05/26 | 142.09%Upside | ||
| Michael SchmidtGuggenheim | BuyReiterated€52.43→€50.62 | 11/04/26 | 118.66%Upside | ||
| Tara BancroftTD Cowen | BuyAssigned€45.20→€54.24 | 08/05/26 | 134.28%Upside | ||
| Paul ChoiGoldman Sachs | HoldReiterated€39.77→€43.39 | 08/05/26 | 87.42%Upside | ||
| Amin MakaremJefferies | BuyInitiated€36.16 | 04/09/26 | 56.19%Upside |
Best Analysts Covering Urogen Pharma
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +18.10% per trade.
Copying Tara Bancroft's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +40.25% per trade.
Copying Tara Bancroft's trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +71.10% per trade.
UR8 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 6 | 8 |
| Buy | 13 | 10 | 8 | 3 | 0 |
| Hold | 2 | 2 | 2 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 19 | 16 | 13 | 10 | 8 |
In the current month, UR8 has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. UR8 average Analyst price target in the past 3 months is 56.22.
UR8 Financial Forecast
UR8 Earnings Forecast
Next quarter’s earnings estimate for UR8 is EUR 0.35 with a range of EUR 0.02 to EUR 0.59. The previous quarter’s EPS was -EUR 0.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
UR8 Sales Forecast
Next quarter’s sales forecast for UR8 is EUR 95.89M with a range of EUR 85.19M to EUR 102.07M. The previous quarter’s sales results were EUR 79.69M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

